Live life to it's

Greatest potential

Our Company

LAVASTA PHARMA is a multi-specialty health care company focused on representing
and commercializing innovative pharmaceuticals and over-the-counter consumer products that enable people to live life to its greatest potential. The company’s services currently extend to cover the region of Africa, Middle East and Turkey.

We have a regional team that manages the strategic execution of commercial operations across the AfMET region with a sales force team on the ground of 150+ across the region

Lavasta has 2 main affiliated companies:

1- Lavasta Pharma FZ-LLC In Dubai, UAE that serves as the main commercial hub for the AFMET Region.
2- Lavasta Pharma LLC- UK in London, UK that serves as the Marketing Authorization and Intellectual Property holding entity.
Read More

Markets

Discover

Algeria

- Hospital treatment, medications, and outpatient care is free to all citizens of Algeria
- The national medical insurance scheme covers 90% of the entire population
- There are over 1500 public hospitals in Algeria
- And over 250 private clinics
- Total Expenditure on health per capita - $932
- Total expenditure on health as % of GDP $7.2

Bahrain

Capital: Manama
Area: 771 square kilometers
Population: 1,3 Million
GDP Total - $34,310 billion

GDP per capita estimated to be $25,494

Djibouti

Capital: Djibouti City
Area: 23,200 km2
Population: 846,687
GDP Total: $2.088 billion

GDP per capita is $2,045

Egypt

Capital: Cairo
Area: 1,010,407.87 square kilometers
Population: 93,687,000
GDP total: $330.765 billion

GDP per capita estimated to be $3,740

Iraq

Capital: Baghdad
Area: 437,072 km2
Population: 38,150,000
GDP: Total $612 billion

GDP per capita is $16,551

Jordan

Capital: Amman
Area: 89,341 km2
Population: 9,916,000.
Demographics: 1,265,000 Syrians, 636,270 Egyptians, 634,182 Palestinians, 130,911 Iraqis, 31,163 Yemenis, 22,700 Libyans and 197,385 from other nationalities residing in the country.
GDP: Total $86.193 billion, Per capita $11,124

KSA

Capital: Riyadh
Area: 2.15 million km²
Population: 33 million
Total GDP: $1.803 trillion

Kuwait

Capital: Kuwait City
Area: 17818 square kilometers
Population: 4  Million (> 60 % are expats)

GDP per capita estimated to be $18,500

Lebanon

Capital: Beirut
Area: 10,452 km2
Population:  6,184,701
GDP Total: $53.915 billion

GDP per capita estimated to be $11,615

Libya

Capital: Tripoli
Area: 1,759,541 km2
Population:  6,541,948
GDP Total: $54.411 billion

GDP per capita estimated to be $11,615

Morocco

Capital: Rabat
Area: 710,850 km2
Population: 33,848,242[
GDP Total: $103.08 billion

GDP per capita estimated to be $3,077

Oman

Capital: Muscat
Area: 309,500 square kilometers
Population: 4,784,417
GDP Total: $71.325 billion

GDP per capita estimated to be $17,485

Qatar

Capital: Doha
Area: 11,581 square kilometers
Population: 2,675,522
GDP total: $185.395 billion

GDP per capita estimated to be $68,940

Somalia

Capital: Mogadishu
Area: 637,657 km2
Population: 14,317,996
GDP Total: $5.8 billion

GDP per capita estimated to be $300–600

Sudan

Capital: Khartoum
Area: 1,886,068 km2
Population: 40,235,000
GDP Total: $115.874 billion
GDP per capita estimated to be $2,841

Tunisia

Capital: Tunis
Area: 163,610 km2
Population: 10,982,754
GDP Total: $40.289 billion

GDP per capita estimated to be $3,553

Turkey

Capital: Ankara

Area: 783,356 km2

Population:  79,814,871

GDP Total: $861 billion

GDP per capita estimated to be $11,014

UAE

Capital: Abu Dhabi
Area: 83,600 km2
Population: 9.2  Million (90% are expats)
GDP: $370.30 Billion USD (2015)

Yemen

Capital: Sana’a
Area: 503,891 km2
Population:  25,408,000
GDP Total: $27.189 billion

GDP per capita estimated to be $907

    Our Products

    Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction patients including those who do not respond or who cannot tolerate or do not accept PDE-5 inhibitor therapy, It combines The power of Alprostadil with a novel topical delivery system NexACT ™.
    Read More
    Vitaros
    Zestra® is a topical medication approved for women with sexual desire and arousal disorders, It is a scientific breakthrough in women’s sexual satisfaction. Doctors and women’s healthcare professionals globally are recommending Zestra – and women are feeling the Zestra Rush.
    Read More
    Zestra
    PROSTAGORX® is a clinical strength, multi response prostate supplement, scientifically formulated to effectively maintain good prostate health and help in prevent prostate issues in the future.
    Read More
    ProstaGorx
    Setofilm is the first and only 5-HT3 antagonist available in an innovative and unique dosage form (oral dispersible film) with approved indications in Prophylaxis and Treatment of acute and delayed Chemotherapy and Radiotherapy Induced Nausea and Vomiting (CINV and RINV) and Post-Operative Nausea and Vomiting (PONV) in adults and children.
    Read More
    SETOFILM
    A High-quality surgical grade mask Type IIR
    Surgical Grade 3 ply face masks
    3 ply construction where all the layers are assembled using sonic press around 40° degrees centigrade temperature.
    50 pieces of Masks that are packed and sealed in a polybag.
    Certified with many reputable standers like:
    CE Conformity 2020-2024
    UAE MOH GMP Certificate 2019-2020
    ISO 13485-2016
    ISO 14001-2015
    ISO 9001_2015
    Proudly Made in UAE
    Read More
    MEDECO Surgical Face Mask

    Contact Us

    If  you have a question concerning our products, career opportunities, businesses or if you are a media representative and require information about Lavasta Pharma please visit our Contact us page for more details.
    Contact